GF
RNAM

Gabelli Funds’s Avidity Biosciences RNAM Stock Holding History

Gabelli Funds’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-328,616
Closed -$23.7M – 1314
2025
Q4 		$23.7M Buy
+328,616
New +$21.2M 0.16% 169

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Gabelli Funds's RNAM Position: Q1 2026 in Review

Gabelli Funds sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 328,616 shares — an estimated $23.7M sold.

Gabelli Funds first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $23.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Gabelli Funds reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Gabelli Funds sold 328,616 Avidity Biosciences shares in Q1 2026, an estimated $23.7M.
  • Gabelli Funds first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Gabelli Funds's Avidity Biosciences position peaked at $23.7M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.